Home / Latest Reports / Generic Injectables Market

Generic Injectables Market By Therapeutic Area (oncology, Anaesthesia, Anti-infectives, Parenteral Nutrition And Cardiovascular) And Distribution Channel (hospitals And Retail Pharmacy Stores) - Global Industry Analysis And Forecast To 2023

Published On : June 2022 Pages : 190 Category: Pharmaceuticals Report Code : HC061055

SEGMENTS & REGIONS:

  • By Therapeutic Area: oncology, Anaesthesia, Anti-infectives, Parenteral Nutrition And Cardiovascular
  • And Distribution Channel: hospitals And Retail Pharmacy Stores
  • Regions: North America, Europe, Asia- Pacific, Latin America, Middle East & Africa

Industry Outlook and Trend Analysis

The Generic Injectable Market is expected to showcase immense growth over the forecast period due to the presence of various driving factors.  Generic Injectable is bio-reciprocals of their marked partners which are not ensured by tranquilize licenses. They are as sheltered and viable as the trend-setter medications since they have comparative dynamic fixing, measurements, quality, frame, and so on. In spite of the fact that the assembling of nonspecific injectable is intricate, their research and development cycle is less expensive and shorter. Dissimilar to marked medication makers who burn through a great many dollars on research and development and advertising, generic drug producers does not require such speculations. In addition, the quantity of rivals in the bland injectable advertises is lower when contrasted with oral generics, bringing about constrained value disintegration and altogether higher overall revenues.

Drivers & Restrains

The developing prevalence of chronic infections and quickly expanding ageing population that are profoundly vulnerable to constant maladies are the essential components affecting emphatically demonstrating huge development in generic injectable market in North America. Developing number of chronic diseases, for example, diabetes and in addition the ensuing ascent sought after for more up to date nonexclusive injectable crosswise over different nations in Europe would additionally fuel development of the market in the district. However, stringent controls by U.S. FDA, for example, observing of the adaptable intravenous (IV) arrangement sacks from presentation to harsh surfaces amid naming and bundling for any infinitesimal punctures or openings on the surface of the pack keeping in mind the end goal to stay away from the tiny deformities that may prompt microbial tainting. Nonetheless, the marked partner of the nonspecific clean injectable is far more costly and therefore, cannot be managed by a typical population. Challenges looked by the assembling organizations in order to meet the rising requests for these injectable in the healing centres, drug stores and medications stores is one of the real worries that may bring about hampering the development of the market. Notwithstanding, different prevailing key holders are associated with gaining little pharmaceutical organizations to fabricate a strong item arrangement of generic injectable to satisfy the request of these drugs.

Regional Outlook and Trend Analysis

North America held the biggest share of the market in 2017. Government activities to expand the rate of diagnosis & reduce treatment expenses, research exercises to enhance management of generic injectable, and solid presence of key players a portion of the components supplementing the development of the area. Asia Pacific is anticipated to encounter the most elevated development over the gauge time frame inferable from developing populace and rising occurrence of autosomal recessive disorders due to consanguineous relational unions in nations, for example, India, Pakistan, and China.

Competitive Insights

The leading players in the market are Baxter, Fresenius Kabi, Hikma, Hospira (Pfizer), Sagent, Sandoz (Novartis) and Sanofi. Many Key players are depending on methods, for example, agreements & joint ventures, collaborations, and advancements to build the visibility of their products and fortify their product portfolios.

The Generic Injectable Market is segmented as follows-

By Therapeutic Area:

  • Oncology
  • Anaesthesia
  • Anti-infective
  • Parenteral Nutrition
  • Cardiovascular

By Distribution Channel:

  • Hospitals
  • Retail Pharmacy Stores

By Region

  • North America
    • U.S.
    • Canada
    • Mexico
  • Europe
    • Germany
    • UK
    • France
    • Russia
    • Italy
    • Rest of Europe
  • Asia-Pacific
    • China
    • Japan
    • South Korea
    • India
    • Southeast Asia
    • Rest of Asia-Pacific
  • South America
    • Brazil
    • Argentina
    • Columbia
    • South Africa
    • Rest of South America
  • Middle East and Africa
    • Saudi Arabia
    • UAE
    • Egypt
    • Nigeria
    • South Africa
    • Rest of MEA

Some of the key questions answered by the report are:

  • What was the market size in 2017 and forecast from 2017 to 2023?
  • What will be the industry market growth from 2017 to 2023?
  • What are the major drivers, restraints, opportunities, challenges, and industry trends and their impact on the market forecast?
  • What are the major segments leading the market growth and why?
  • Which are the leading players in the market and what are the major strategies adopted by them to sustain the market competition?

Market Classification

·         Generic Injectables Market, By Therapeutic Area, Estimates and Forecast, 2014-2023 ($Million)

·         Oncology

·         Anaesthesia

·         Anti-infectives

·         Parenteral Nutrition

·         Cardiovascular

·         Generic Injectables Market, By Distribution Channel, Estimates and Forecast, 2014-2023 ($Million)

·         Hospitals

·         Retail Pharmacy Stores

·         Generic Injectables Market, By Region, Estimates and Forecast, 2014-2023 ($Million)

·         North America

§  North America Generic Injectables Market, By Country

o    U.S. Generic Injectables Market

o    Canada Generic Injectables Market

o    Mexico Generic Injectables Market

·         Europe

§  Europe Generic Injectables Market, By Country

o    Germany Generic Injectables Market

o    UK Generic Injectables Market

o    France Generic Injectables Market

o    Russia Generic Injectables Market

o    Italy Generic Injectables Market

o    Rest of Europe Generic Injectables Market

·         Asia-Pacific

§  Asia-Pacific Generic Injectables Market, By Country

o    China Generic Injectables Market

o    Japan Generic Injectables Market

o    South Korea Generic Injectables Market

o    India Generic Injectables Market

o    Southeast Asia Generic Injectables Market

o    Rest of Asia-Pacific Generic Injectables Market

·         South America

§  South America Generic Injectables Market

o    Brazil Generic Injectables Market

o    Argentina Generic Injectables Market

o    Columbia Generic Injectables Market

o    South Africa Generic Injectables Market

o    Rest of South America Generic Injectables Market

·         Middle East and Africa

§  Middle East and Africa Generic Injectables Market

o    Saudi Arabia Generic Injectables Market

o    UAE Generic Injectables Market

o    Egypt Generic Injectables Market

o    Nigeria Generic Injectables Market

o    South Africa Generic Injectables Market

o    Rest of MEA Generic Injectables Market

Table of Contents

1.       Introduction

1.1.       Report Description

1.2.       Research Methodology

1.2.1.  Secondary Research

1.2.2.  Primary Research

2.       Executive Summary

2.1.       Key Highlights

3.       Market Overview

3.1.       Introduction

3.1.1.  Market Definition

3.1.2.  Market Segmentation

3.2.       Market Dynamics

3.2.1.  Drivers

3.2.2.  Restraints

3.2.3.  Opportunities

3.2.3.1.    Emerging Markets to Offer Lucrative Growth Opportunities

4.       Market Analysis by Regions

4.1.       North America (United States, Canada and Mexico)

4.1.1.  United States Market States and Outlook (2017-2023)

4.1.2.  Canada Market States and Outlook (2017-2023)

4.1.3.  Mexico Market States and Outlook (2017-2023)

4.2.       Europe (Germany, France, UK, Russia, Italy and Rest of Europe)

4.2.1.  Germany Market States and Outlook (2017-2023)

4.2.2.  France Market States and Outlook (2017-2023)

4.2.3.  UK Market States and Outlook (2017-2023)

4.2.4.  Russia Market States and Outlook (2017-2023)

4.2.5.  Italy Market States and Outlook (2017-2023)

4.2.6.  Rest of Europe Market States and Outlook (2017-2023)

4.3.       Asia-Pacific (China, Japan, Korea, India, Southeast Asia and Rest of Asia-Pacific)

4.3.1.  China Market States and Outlook (2017-2023)

4.3.2.  Japan Market States and Outlook (2017-2023)

4.3.3.  Korea Market States and Outlook (2017-2023)

4.3.4.  India Market States and Outlook (2017-2023)

4.3.5.  Rest of Asia-Pacific Market States and Outlook (2017-2023)

4.4.       South America (Brazil, Argentina, Columbia and Rest of South America)

4.4.1.  Brazil Market States and Outlook (2017-2023)

4.4.2.  Argentina Market States and Outlook (2017-2023)

4.4.3.  Columbia Market States and Outlook (2017-2023)

4.4.4.  Rest of South America Market States and Outlook (2017-2023)

4.5.       Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa and Rest of MEA)

4.5.1.  Saudi Arabia Market States and Outlook (2017-2023)

4.5.2.  UAE Market States and Outlook (2017-2023)

4.5.3.  Egypt Market States and Outlook (2017-2023)

4.5.4.  Nigeria Market States and Outlook (2017-2023)

4.5.5.  South Africa Market States and Outlook (2017-2023)

4.5.6.  Rest of MEA Market States and Outlook (2017-2023)

5.       Generic Injectables Market, By Therapeutic Area

5.1.       Introduction

5.2.       Global Generic Injectables Sales, Revenue and Market Share by Therapeutic Area (2017-2027)

5.2.1.  Global Generic Injectables Sales and Sales Share by Therapeutic Area (2017-2027)

5.2.2.  Global Generic Injectables Revenue and Revenue Share by Therapeutic Area (2017-2027)

5.3.       Oncology

5.3.1.  Global Oncology Sales and Growth Rate (2017-2027)

5.4.       Anaesthesia

5.4.1.  Global Anaesthesia Sales and Growth Rate (2017-2027)

5.5.       Anti-infectives

5.5.1.  Global Anti-infectives Sales and Growth Rate (2017-2027)

5.6.       Parenteral Nutrition

5.6.1.  Global Parenteral Nutrition Sales and Growth Rate (2017-2027)

5.7.       Cardiovascular

5.7.1.  Global Cardiovascular Sales and Growth Rate (2017-2027)

6.       Generic Injectables Market, By Distribution Channel

6.1.       Introduction

6.2.       Global Generic Injectables Sales, Revenue and Market Share by Distribution Channel (2017-2027)

6.2.1.  Global Generic Injectables Sales and Sales Share by Distribution Channel (2017-2027)

6.2.2.  Global Generic Injectables Revenue and Revenue Share by Distribution Channel (2017-2027)

6.3.       Hospitals

6.3.1.  Global Hospitals Sales and Growth Rate (2017-2027)

6.4.       Retail Pharmacy Stores

6.4.1.  Global Retail Pharmacy Stores Sales and Growth Rate (2017-2027)

7.       Generic Injectables Market, By Region

7.1.       Introduction

7.2.       Global Generic Injectables Sales, Revenue and Market Share by Regions

7.2.1.  Global Generic Injectables Sales by Regions (2017-2027)

7.2.2.  Global Generic Injectables Revenue by Regions (2017-2027)

7.3.       North America Generic Injectables by Countries

7.3.1.  North America Generic Injectables Sales and Growth Rate (2017-2027)

7.3.2.  North America Generic Injectables Revenue and Growth Rate (2017-2027)

7.3.3.  North America Generic Injectables Sales by Countries (2017-2027)

7.3.4.  North America Generic Injectables Revenue (Million USD) by Countries (2017-2027)

7.3.5.  U.S.

7.3.5.1.    United States Generic Injectables Sales and Growth Rate (2017-2027)

7.3.5.2.    United States Generic Injectables Revenue (Millions USD) and Growth Rate (2017-2027)

7.3.6.  Canada

7.3.6.1.    Canada Generic Injectables Sales and Growth Rate (2017-2027)

7.3.6.2.    Canada Generic Injectables Sales (Millions USD) and Growth Rate (2017-2027)

7.3.7.  Mexico

7.3.7.1.    Mexico Generic Injectables Sales and Growth Rate (2017-2027)

7.3.7.2.    Mexico Generic Injectables Revenue (Millions USD) and Growth Rate (2017-2027)

7.4.       Europe Generic Injectables by Countries

7.4.1.  Europe Generic Injectables Sales and Growth Rate (2017-2027)

7.4.2.  Europe Generic Injectables Revenue and Growth Rate (2017-2027)

7.4.3.  Europe Generic Injectables Sales by Countries (2017-2027)

7.4.4.  Europe Generic Injectables Revenue (Million USD) by Countries (2017-2027)

7.4.5.  Germany

7.4.5.1.    Germany Generic Injectables Sales and Growth Rate (2017-2027)

7.4.5.2.    Germany Generic Injectables Revenue (Millions USD) and Growth Rate (2017-2027)

7.4.6.  UK

7.4.6.1.    UK Generic Injectables Sales and Growth Rate (2017-2027)

7.4.6.2.    UK Generic Injectables Revenue (Millions USD) and Growth Rate (2017-2027)

7.4.7.  France

7.4.7.1.    France Generic Injectables Sales and Growth Rate (2017-2027)

7.4.7.2.    France Generic Injectables Revenue (Millions USD) and Growth Rate (2017-2027)

7.4.8.  Russia

7.4.8.1.    Russia Generic Injectables Sales and Growth Rate (2017-2027)

7.4.8.2.    Russia Generic Injectables Revenue (Millions USD) and Growth Rate (2017-2027)

7.4.9.  Italy

7.4.9.1.    Italy Generic Injectables Sales and Growth Rate (2017-2027)

7.4.9.2.    Italy Generic Injectables Revenue (Millions USD) and Growth Rate (2017-2027)

7.4.10.      Rest of Europe

7.4.10.1. Rest of Europe Generic Injectables Sales and Growth Rate (2017-2027)

7.4.10.2. Rest of Europe Generic Injectables Revenue (Millions USD) and Growth Rate (2017-2027)

7.5.       Asia-Pacific

7.5.1.  Asia-Pacific Generic Injectables Sales and Growth Rate (2017-2027)

7.5.2.  Asia-Pacific Generic Injectables Revenue and Growth Rate (2017-2027)

7.5.3.  Asia-Pacific Generic Injectables Sales by Countries (2017-2027)

7.5.4.  Asia-Pacific Generic Injectables Revenue (Million USD) by Countries (2017-2027)

7.5.5.  China

7.5.5.1.    China Generic Injectables Sales and Growth Rate (2017-2027)

7.5.5.2.    China Generic Injectables Revenue (Millions USD) and Growth Rate (2017-2027)

7.5.6.  Japan

7.5.6.1.    Japan Generic Injectables Sales and Growth Rate (2017-2027)

7.5.6.2.    Japan Generic Injectables Revenue (Millions USD) and Growth Rate (2017-2027)

7.5.6.3.     

7.5.7.  Korea

7.5.7.1.    Korea Generic Injectables Sales and Growth Rate (2017-2027)

7.5.7.2.    Korea Generic Injectables Revenue (Millions USD) and Growth Rate (2017-2027)

7.5.8.  India

7.5.8.1.    India Generic Injectables Sales and Growth Rate (2017-2027)

7.5.8.2.    India Generic Injectables Revenue (Millions USD) and Growth Rate (2017-2027)

7.5.9.  Southeast Asia

7.5.9.1.    Southeast Asia Generic Injectables Sales and Growth Rate (2017-2027)

7.5.9.2.    Southeast Asia Generic Injectables Revenue (Millions USD) and Growth Rate (2017-2027)

7.5.10.      Rest of Asia-Pacific

7.5.10.1. Rest of Asia-Pacific Generic Injectables Sales and Growth Rate (2017-2027)

7.5.10.2. Rest of Asia-Pacific Generic Injectables Revenue (Millions USD) and Growth Rate (2017-2027)

7.6.       South America

7.6.1.  South America Generic Injectables Sales and Growth Rate (2017-2027)

7.6.2.  South America Generic Injectables Revenue and Growth Rate (2017-2027)

7.6.3.  South America Generic Injectables Sales by Countries (2017-2027)

7.6.4.  South America Generic Injectables Revenue (Million USD) by Countries (2017-2027)

7.6.5.  Brazil

7.6.5.1.    Brazil Generic Injectables Sales and Growth Rate (2017-2027)

7.6.5.2.    Brazil Generic Injectables Revenue (Millions USD) and Growth Rate (2017-2027)

7.6.6.  Argentina

7.6.6.1.    Argentina Generic Injectables Sales and Growth Rate (2017-2027)

7.6.6.2.    Argentina Generic Injectables Revenue (Millions USD) and Growth Rate (2017-2027)

7.6.7.  Columbia

7.6.7.1.    Columbia Generic Injectables Sales and Growth Rate (2017-2027)

7.6.7.2.    Columbia Generic Injectables Revenue (Millions USD) and Growth Rate (2017-2027)

7.6.8.  Rest of South America

7.6.8.1.    Rest of South America Generic Injectables Sales and Growth Rate (2017-2027)

7.6.8.2.    Rest of South America Generic Injectables Revenue (Millions USD) and Growth Rate (2017-2027)

7.7.       Middle East and Africa

7.7.1.  Middle East and Africa Generic Injectables Sales and Growth Rate (2017-2027)

7.7.2.  Middle East and Africa Generic Injectables Revenue and Growth Rate (2017-2027)

7.7.3.  Middle East and Africa Generic Injectables Sales by Countries (2017-2027)

7.7.4.  Middle East and Africa Generic Injectables Revenue (Million USD) by Countries (2017-2027)

7.7.5.  Saudi Arabia

7.7.5.1.    Saudi Arabia Generic Injectables Sales and Growth Rate (2017-2027)

7.7.5.2.    Saudi Arabia Generic Injectables Revenue (Millions USD) and Growth Rate (2017-2027)

7.7.6.  United Arab Emirates

7.7.6.1.    United Arab Emirates Generic Injectables Sales and Growth Rate (2017-2027)

7.7.6.2.    United Arab Emirates Generic Injectables Revenue (Millions USD) and Growth Rate (2017-2027)

7.7.7.  Egypt

7.7.7.1.    Egypt Generic Injectables Sales and Growth Rate (2017-2027)

7.7.7.2.    Egypt Generic Injectables Revenue (Millions USD) and Growth Rate (2017-2027)

7.7.8.  Nigeria

7.7.8.1.    Nigeria Generic Injectables Sales and Growth Rate (2017-2027)

7.7.8.2.    Nigeria Generic Injectables Revenue (Millions USD) and Growth Rate (2017-2027)

7.7.9.  South Africa

7.7.9.1.    South Africa Generic Injectables Sales and Growth Rate (2017-2027)

7.7.9.2.    South Africa Generic Injectables Revenue (Millions USD) and Growth Rate (2017-2027)

7.7.10.      Rest of Middle East and Africa

7.7.10.1. Rest of Middle East and Africa Generic Injectables Sales and Growth Rate (2017-2027)

7.7.10.2. Rest of Middle East and Africa Generic Injectables Revenue (Millions USD) and Growth Rate (2017-2027)

8.       Company Profiles

8.1.         Baxter

8.1.1.  Business Overview

8.1.2.  Product Portfolio

8.1.3.  Strategic Developments

8.1.4.  Sales, Revenue and Market Share

8.2.       Fresenius Kabi

8.2.1.  Business Overview

8.2.2.  Product Portfolio

8.2.3.  Strategic Developments

8.2.4.  Sales, Revenue and Market Share

8.3.       Hikma

8.3.1.  Business Overview

8.3.2.  Product Portfolio

8.3.3.  Strategic Developments

8.3.4.  Sales, Revenue and Market Share

8.4.       Hospira (Pfizer)

8.4.1.  Business Overview

8.4.2.  Product Portfolio

8.4.3.  Strategic Developments

8.4.4.  Sales, Revenue and Market Share

8.5.       Sagent

8.5.1.  Business Overview

8.5.2.  Product Portfolio

8.5.3.  Strategic Developments

8.5.4.  Sales, Revenue and Market Share

8.6.       Sandoz (Novartis)

8.6.1.  Business Overview

8.6.2.  Product Portfolio

8.6.3.  Strategic Developments

8.6.4.  Sales, Revenue and Market Share

8.7.        Sanofi

8.7.1.  Business Overview

8.7.2.  Product Portfolio

8.7.3.  Strategic Developments

8.7.4.  Sales, Revenue and Market Share

9.       Global Generic Injectables Market Competition, by Manufacturer

9.1.       Global Generic Injectables Sales and Market Share by Manufacturer (2017-2017)

9.2.       Global Generic Injectables Revenue and Market Share by Manufacturer (2017-2017)

9.3.       Global Generic Injectables Price by Manufacturer (2017-2017)

9.4.       Top 5 Generic Injectables Manufacturer Market Share

9.5.       Market Competition Trend

10.   Generic Injectables Market Forecast (2027-2023)

10.1.    Global Generic Injectables Sales, Revenue (Millions USD) and Growth Rate (2027-2023)

10.2.    Generic Injectables Market Forecast by Regions (2027-2023)

10.2.1.      North America Generic Injectables Market Forecast (2027-2023)

10.2.1.1. United States Generic Injectables Market Forecast (2027-2023)

10.2.1.2. Canada Generic Injectables Market Forecast (2027-2023)

10.2.1.3. Mexico Generic Injectables Market Forecast (2027-2023)

10.2.2.      Europe Generic Injectables Market Forecast (2027-2023)

10.2.2.1. Germany Generic Injectables Market Forecast (2027-2023)

10.2.2.2. United Kingdom Generic Injectables Market Forecast (2027-2023)

10.2.2.3. France Generic Injectables Market Forecast (2027-2023)

10.2.2.4. Russia Generic Injectables Market Forecast (2027-2023)

10.2.2.5. Italy Generic Injectables Market Forecast (2027-2023)

10.2.2.6. Rest of the Europe Generic Injectables Market Forecast (2027-2023)

10.2.3.      Asia-Pacific Generic Injectables Market Forecast (2027-2023)

10.2.3.1. China Generic Injectables Market Forecast (2027-2023)

10.2.3.2. Japan Generic Injectables Market Forecast (2027-2023)

10.2.3.3. Korea Generic Injectables Market Forecast (2027-2023)

10.2.3.4. India Generic Injectables Market Forecast (2027-2023)

10.2.3.5. Southeast Asia Generic Injectables Market Forecast (2027-2023)

10.2.3.6. Rest of Asia-Pacific Generic Injectables Market Forecast (2027-2023)

10.2.4.      South America Generic Injectables Market Forecast (2027-2023)

10.2.4.1. Brazil Generic Injectables Market Forecast (2027-2023)

10.2.4.2. Argentina Generic Injectables Market Forecast (2027-2023)

10.2.4.3. Columbia Generic Injectables Market Forecast (2027-2023)

10.2.4.4. Rest of South America Generic Injectables Market Forecast (2027-2023)

10.2.5.      Middle East and Africa Generic Injectables Market Forecast (2027-2023)

10.2.5.1. Saudi Arabia Generic Injectables Market Forecast (2027-2023)

10.2.5.2. UAE Generic Injectables Market Forecast (2027-2023)

10.2.5.3. Egypt Generic Injectables Market Forecast (2027-2023)

10.2.5.4. Nigeria Generic Injectables Market Forecast (2027-2023)

10.2.5.5. South Africa Generic Injectables Market Forecast (2027-2023)

10.2.5.6. Rest of MEA Generic Injectables Market Forecast (2027-2023)

10.3.    Generic Injectables Market Forecast by Therapeutic Area (2027-2023)

10.3.1.      Global Generic Injectables Sales Forecast by Therapeutic Area (2027-2023)

10.3.2.      Global Generic Injectables Sales Market Share Forecast by Therapeutic Area (2027-2023)

10.4.    Generic Injectables Market Forecast by Distribution Channel (2027-2023)

10.4.1.      Global Generic Injectables Sales Forecast by Distribution Channel (2027-2023)

10.4.2.      Global Generic Injectables Sales Market Share Forecast by Distribution Channel (2027-2023)

List of Tables

*You can glance through the list of Tables and Figures when you view the sample copy of Generic Injectables Market.

Research Methodology

We use both primary as well as secondary research for our market surveys, estimates and for developing forecast. Our research process commence by analyzing the problem which enable us to design the scope for our research study. Our research process is uniquely designed with enough flexibility to adjust according to changing nature of products and markets, while retaining core element to ensure reliability and accuracy in research findings. We understand both macro and micro-economic factors to evaluate and forecast different market segments.

Data Mining

Data is extensively collected through various secondary sources such as annual reports, investor presentations, SEC filings, and other corporate publications. We also refer trade magazines, technical journals, paid databases such as Factiva and Bloomberg, industry trade journals, scientific journals, and social media data to understand market dynamics and industry trends. Further, we also conduct primary research to understand market drivers, restraints, opportunities, challenges, and competitive scenario to build our analysis.

Data Collection Matrix

Data Collection Matrix

Supply Side

Demand Side

Primary Data Sources
  • Manufacturers
  • Distributors & Wholesalers
  • GPOs
  • Physicians/Specialist
  • Healthcare Providers
  • Consumers

Secondary Data Sources
  • Annual Reports/SEC Filings/ Investor Presentations/ Press Releases
  • Government/Associations Publications
  • Case Studies
  • Reference Customers

 

Market Modeling and Forecasting

We use epidemiology and capital equipment-based models to forecast market size of different segments at country and regional level.

  • Epidemiology-based Forecasting Model: This method uses epidemiology data gathered through various publications and from physicians to estimate population of patients, flow of treatment of individual disease and therapies. The data collected through this method includes statics on incidence of disease, population suffering from disease, and treatment population. This method is used to understand:
  • Number of patients for particular device or medical procedure and
  • Repeated use of particular device depending on health and condition of patient
  • Capital-based Forecasting Model: This method of forecasting is based on number of replacements, installed-based and new sales of capital equipment used in various healthcare and diagnostic centers. These three parameters are calculated and forecast is developed. Installation base is calculated as average number of units per facility; while sales for particular year is calculated from number of new and replace units. Secondary data is collected through various supply chain intermediaries and opinion leaders to arrive at installation and sales rate. These techniques help our analysts in validating market and developed market estimates and forecast.

We do forecast on basis of several parameters such as market drivers, market opportunities, industry trends government regulations, raw materials supply and trade dynamics to ensure relevance of forecast with market scenario. With increasing need to granulized information, we used bottom-up methodology for forecasting where we evaluate each regional segment differently and combined all forecast to develop final market forecast.

Data Validation

We believe primary research is a very important tool in analyzing and forecasting different markets. In order to make sure accuracy of our findings, our team conducts primary interviews at every stage of research to gain deep insights into current business environment and future trends and key developments in market. This includes use of various methods such as telephonic interviews, focus groups, face to face interviews and questionnaires to validate our research from all aspects. We validate our data through primary research from key industry leaders such as CEO, product managers, marketing managers, suppliers, distributors, and consumers are frequently interviewed. These interviews provide valuable insights which help us to have better market understanding besides validating our estimates and forecast.

Data Triangulation

data triangulation

Industry Analysis

Qualitative Data

Quantitative Data (2017-2025)
  • Market Dynamics (Drivers, Restraints, and Challenges)
  • Industry Trend Analysis
  • Market Opportunities
  • Government Policies and Regulations, Patent Analysis, and Reimbursement Policies
  • Porter’s Five Forces and PESTLE Analysis
  • Key Developments and Competitive Landscape
  • Market Assessment and Forecast
  • Market Assessment and Forecast, By Product
  • Market Assessment and Forecast, By Technology
  • Market Assessment and Forecast, By Application
  • Market Assessment and Forecast, By End User
  • Market Assessment and Forecast, By Region/Country

Request Sample Enquire Before Buying Request for Customization

Request Sample